BTIG Defending GeneDx (WGS)

Go back to BTIG Defending GeneDx (WGS)

Jefferies Reiterates Hold Rating on GeneDx (WGS)

February 5, 2025 3:51 PM EST

Jefferies analyst Tycho Peterson reiterated a Hold rating and $75.00 price target on GeneDx (NASDAQ: WGS).

The analyst comments "A short report on WGS has alleged fraud (such as illegal code-stacking), citing ex-employee testimony and a known '22 reimbursement liability as evidence (with... More

Craig-Hallum on GeneDx Holdings (WGS): 'Would Buy on Weakness' (Tuesday)

February 5, 2025 1:44 PM EST

(Updated - February 6, 2025 8:31 AM EST)

Craig-Hallum on GeneDx Holdings (NASDAQ: WGS): 'Would Buy on Weakness'

The analyst comments "This morning Grizzly Research issued a short report on GeneDx (WGS). The primary allegation is that GeneDx utilizes an illegal code-stacking scheme to... More

Grizzly Research is short GeneDx Holdings (WGS)

February 5, 2025 9:47 AM EST

(Updated - February 5, 2025 9:48 AM EST)

Grizzly Research is short GeneDx Holdings (NASDAQ: WGS)

We are short GeneDx $WGS; Insiders attest that GeneDx (Nasdaq: WGS) is actively committing widespread fraudGeneDx $WGS, before its name... More